Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Syneos Health Inc (NQ: SYNH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Syneos Health Inc

< Previous 1 2 3 4 Next >
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports Arbitration Panel Finding in Syneos Health (NASDAQ: SYNH) Proceeding
Via Investor Brand Network
Exposures Product Safety
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer
Human Resources Leader with Nearly 30 Years of Experience and Commitment to Professional Services Environment 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
Integrated eCOA & ePRO Solution Taps Company’s Decentralized Capabilities and Technology Expertise 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
Newly Created Role Demonstrates Commitment to Improve Diversity in Clinical Trials and Commercialization Across Organization 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Leaders Recognized by HBA
Healthcare Businesswomen’s Association Spotlights Jennifer Sozio and Caitlin Purinai for Biopharma Industry Impact 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
Company Executives Honored for Notable Biopharmaceutical Industry Impact 
From Syneos Health, Inc.
Via GlobeNewswire
SYNEOS HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Syneos Health, Inc. - SYNH
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Syneos Health, Inc. (Nasdaq – SYNH), Franchise Group, Inc. (Nasdaq – FRG), CTI BioPharma Corp. (Nasdaq – CTIC), Ruth’s Inc. (Nasdaq – RUTH)
From Brodsky & Smith LLC
Via GlobeNewswire
SYNH STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Syneos Health, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Syneos Health Reports First Quarter 2023 Results
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Appoints Michael Bonello as Chief Financial Officer
Finance Leader with 30+ Years of Experience, Including 15 Years in Clinical Research Industry 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Wins 2023 ViE Award
Company Recognized for Positive Vaccine Expertise Contributions 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Names Jeanine O’Kane as Communications President
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Launches Medical Affairs Digital Amplifier
Program Drives Digital and Omnichannel Engagement for Medical Science Liaison Teams & Medical Conferences 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial Execution 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
Newly Established Network Will Enable High Quality DCTs & Digital Health Technology Solutions 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
Combined Capabilities Will Help Improve Trial Lifecycles for Patients, Sites & Sponsors 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
Relationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial Solutions 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023
Despite Uncertainties, Survey Hints that Dealmaking Intensity Could Be Poised for a Rebound After a Year of Inertia 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Announces Chief Financial Officer Transition
Reaffirms Full-Year 2022 Revenue Guidance 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Extends Partnership with Medable
Continued Collaboration Will Accelerate Bringing Clinical Trials Closer to the Patient 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Releases 2023 Health Trends
Predicts AI and Machine Learning, Diversity and Medical Affairs will Transform Biopharma Product Development 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
From Syneos Health, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.